Karnataka Government Backs Biotech Firm with New Investment!
Great news for the biotech world! Mysuru’s very own Vipragen Biosciences has just secured another round of investment that’s set to take its operations to a whole new level.
This time, it’s the Karnataka Information Technology Venture Capital Fund (KITVEN) and the Conscience Multi Family Office LLP that are stepping up to support Vipragen’s journey. With a boost from these esteemed investors, Vipragen is gearing up for some major expansion and growth in the field.
But what exactly does this investment mean for Vipragen? Well, according to Dr. Chandrashekaran, the brains behind Vipragen, this funding is like rocket fuel for their plans. They’re looking to broaden their horizons beyond the usual by diving into sectors like Nutraceuticals, Agrochemicals, and even Medical Devices. And guess what? Their unique expertise in the preclinical Contract Research Organization (CRO) space is making them a top choice for strategic partnerships worldwide.
KITVEN’s CEO, Mr. Jayakumar, is all smiles about this partnership too. He’s seeing Vipragen as a trailblazer in the CRO world, set to become a powerhouse for both pharmaceutical companies and research organizations.
And that’s not all! Vipragen is also getting some expert guidance from Conscience
MFO, a Chennai-based team that knows the ropes of the preclinical CRO landscape.Backing this exciting move is QuantAscend Consulting Global, who’ve led and advised the investment deal. And if you’re wondering if this is Vipragen’s first rodeo with funding, think again. They’ve previously scored funding from KITVEN and have even had a helping hand from BIRAC in their collaborative projects.
But the story doesn’t stop there. Vipragen has a pretty cool origin story—it was incubated at the Centre for Cellular and Molecular Platforms (CCAMP) in Bangalore. And with this new funding in their pockets, they’re all set to expand their operations and explore fresh territory in Nutraceuticals, Agrochemicals, and Medical Devices.
Dr. Chandrashekaran, the Founder Chairman, is super optimistic about India’s role as a global research hotspot. He’s got his sights set on attracting international companies to tap into India’s thriving research ecosystem.
So, hold onto your lab coats because Vipragen is gearing up for some big things in the biotech world!
Karnataka Government Backs Biotech Firm with New Investment!
